Clinical Trial Update: PG2 Treatment Among Stage II/III Breast Cancer Patients Receiving Adjuvant Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating PG2 in stage II/III breast cancer patients receiving adjuvant chemotherapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• PG2

Snippet

Sponsor: PhytoHealth Corporation | Conditions: Cancer-related Fatigue, Neutropenia, Malignant | Phase 2 | Status: COMPLETED